NEXGEL (NXGL) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Special Meeting scheduled for November 26, 2025, to vote on increasing authorized common stock from 25,000,000 to 1,000,000,000 shares, subject to Board implementation.
Board unanimously recommends voting in favor of the Authorized Share Increase Proposal.
The amendment aims to provide flexibility for future capital raising, strategic transactions, and other corporate needs.
No other matters are expected to be presented at the meeting.
Voting matters and shareholder proposals
Only one proposal: to approve an amendment increasing authorized common stock to 1,000,000,000 shares.
Stockholders of record as of October 20, 2025, are eligible to vote; each share has one vote.
Voting can be done via Internet, phone, mail, or in person; proxies are revocable before the meeting.
Board recommends a "FOR" vote; majority of outstanding shares required for approval.
No dissenters' or appraisal rights are available for this proposal.
Board of directors and corporate governance
Board has discretion to implement the Authorized Share Increase within twelve months if approved.
Adam Levy and Joseph McGuire appointed as proxies for the meeting.
Stockholder proposals for the 2026 annual meeting must comply with bylaw notice provisions.
Latest events from NEXGEL
- Hydrogel innovation and strategic partnerships fuel rapid growth and expanding product lines.NXGL
Planet MicroCap Showcase: VEGAS 20253 Feb 2026 - Record Q2 revenue and strong outlook driven by branded products and Silly George growth.NXGL
Q2 20242 Feb 2026 - Q3 revenue up 141% to $2.94M, gross margin 43.6%, but losses and risks persist.NXGL
Q3 202414 Jan 2026 - Strong growth from product innovation, acquisitions, and major partnerships, with profitability in focus.NXGL
IAccess Alpha–Buyside Best Ideas Winter Virtual Conference 202411 Jan 2026 - Record revenue growth and improved margins set stage for positive EBITDA in 2025.NXGL
Q4 202424 Dec 2025 - Shareholders will vote on director elections, incentive plan expansion, and executive pay, all backed by the Board.NXGL
Proxy Filing2 Dec 2025 - Q1 2025 revenue up 121%, margin at 42.4%, and positive EBITDA targeted for 2025.NXGL
Q1 202527 Nov 2025 - Q2 2025 revenue doubled and margins improved, but going concern risks persist.NXGL
Q2 202523 Nov 2025 - Q3 revenue steady at $2.93M, gross margin up, nine-month revenue up 52.7%, risks persist.NXGL
Q3 202517 Nov 2025